PHYH

phytanoyl-CoA 2-hydroxylase

Basic information

Region (hg38): 10:13277796-13302412

Links

ENSG00000107537NCBI:5264OMIM:602026HGNC:8940Uniprot:O14832AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • adult Refsum disease (Strong), mode of inheritance: AR
  • adult Refsum disease (Definitive), mode of inheritance: AR
  • adult Refsum disease (Supportive), mode of inheritance: AR
  • adult Refsum disease (Definitive), mode of inheritance: AR
  • phytanoyl-CoA hydroxylase deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Refsum diseaseARBiochemical; Cardiovascular; PharmacogenomicDietary measures (high calorie diet with phytanic acid restriction) may be beneficial; Surveillance can allow early diagnosis and treatment of cardiac manifestsations (eg, cardiac arrhythmias, cardiomyopathy); Plasmapheresis/lipid apheresis may be indicated in severe situations; Certain agents/circumstances (eg, fasting, ibuprofen) should be avoidedAudiologic/Otolaryngologic; Biochemical; Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic13045168; 18140089; 4159604; 85164; 6160883; 2452736; 9326939; 9326940; 10767344; 17905308; 20301527; 20547622; 22156782

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PHYH gene.

  • not provided (23 variants)
  • Phytanic acid storage disease (6 variants)
  • Refsum syndrome (1 variants)
  • Refsum disease, adult, 1 (1 variants)
  • Retinitis pigmentosa (1 variants)
  • PHYH-related disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHYH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
95
clinvar
2
clinvar
101
missense
1
clinvar
5
clinvar
133
clinvar
1
clinvar
2
clinvar
142
nonsense
10
clinvar
7
clinvar
2
clinvar
19
start loss
2
clinvar
2
frameshift
10
clinvar
13
clinvar
23
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
15
clinvar
17
splice region
11
15
26
non coding
11
clinvar
75
clinvar
30
clinvar
116
Total 23 40 155 171 34

Highest pathogenic variant AF is 0.000177

Variants in PHYH

This is a list of pathogenic ClinVar variants found in the PHYH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-13277802-G-A Phytanic acid storage disease Uncertain significance (Jan 13, 2018)877811
10-13277867-T-C Phytanic acid storage disease Uncertain significance (Jan 12, 2018)877812
10-13277884-T-C Phytanic acid storage disease Uncertain significance (Jan 12, 2018)877813
10-13278048-C-A Phytanic acid storage disease Uncertain significance (Jan 12, 2018)877814
10-13278111-GT-G Phytanic acid storage disease Benign (Aug 10, 2019)299239
10-13278111-G-GT Benign (Aug 22, 2019)1223081
10-13278113-T-G Phytanic acid storage disease Uncertain significance (Jan 13, 2018)877815
10-13278236-C-T Phytanic acid storage disease Benign (Aug 07, 2018)299240
10-13278254-C-T Phytanic acid storage disease Likely benign (Jan 13, 2018)299241
10-13278276-G-A Phytanic acid storage disease Uncertain significance (Jan 12, 2018)877978
10-13278279-A-C Phytanic acid storage disease Likely benign (Jan 13, 2018)299242
10-13278304-A-G PHYH-related disorder Likely benign (Jan 08, 2024)1639769
10-13278305-A-AGAT Nonsyndromic cleft lip palate • not specified Conflicting classifications of pathogenicity (Mar 01, 2024)444210
10-13278307-A-T Inborn genetic diseases Uncertain significance (May 08, 2023)2519911
10-13278308-T-C Uncertain significance (Dec 02, 2021)1475761
10-13278309-T-C Phytanic acid storage disease Uncertain significance (Jul 30, 2019)299243
10-13278312-T-G Uncertain significance (Apr 28, 2022)2046347
10-13278327-C-G Inborn genetic diseases Uncertain significance (Oct 04, 2022)837093
10-13278332-C-G Uncertain significance (Mar 29, 2021)1461355
10-13278332-C-T Uncertain significance (Dec 11, 2023)943839
10-13278333-G-A Uncertain significance (Jun 14, 2022)2178043
10-13278335-G-C Uncertain significance (Apr 11, 2022)2124716
10-13278337-T-C Likely benign (Jan 07, 2023)2824968
10-13278338-C-A Uncertain significance (Jul 12, 2022)1055584
10-13278338-C-T Phytanic acid storage disease • PHYH-related disorder Likely benign (Jan 27, 2024)299244

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PHYHprotein_codingprotein_codingENST00000263038 924617
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002380.7441256890591257480.000235
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.03101941950.9940.00001132245
Missense in Polyphen5353.7780.98554597
Synonymous0.2927275.20.9570.00000522619
Loss of Function1.201116.20.6786.96e-7200

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002970.000297
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.0004620.000462
European (Non-Finnish)0.0003170.000316
Middle Eastern0.0001630.000163
South Asian0.00003270.0000327
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA.;
Pathway
Peroxisome - Homo sapiens (human);Oxidation of Branched Chain Fatty Acids;Refsum Disease;Phytanic Acid Peroxisomal Oxidation;Metabolism of lipids;Metabolism of proteins;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism;Peroxisomal protein import;Fatty acid metabolism;Phytanic acid peroxisomal oxidation;TYSND1 cleaves peroxisomal proteins;fatty acid α-oxidation (Consensus)

Recessive Scores

pRec
0.229

Intolerance Scores

loftool
0.119
rvis_EVS
0.62
rvis_percentile_EVS
83.36

Haploinsufficiency Scores

pHI
0.0601
hipred
N
hipred_score
0.377
ghis
0.476

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.670

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Phyh
Phenotype
immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);

Gene ontology

Biological process
fatty acid alpha-oxidation;2-oxoglutarate metabolic process;protein targeting to peroxisome;isoprenoid metabolic process;methyl-branched fatty acid metabolic process
Cellular component
peroxisome;peroxisomal matrix;cytosol
Molecular function
protein binding;ferrous iron binding;carboxylic acid binding;L-ascorbic acid binding;cofactor binding;phytanoyl-CoA dioxygenase activity